Call it a PrEP to protect against heart disease in people with HIV.
hivequal.org
A large, multi-site clinical trial dubbed REPRIEVE has begun enrolling across the U.S. and around the world to examine whether a medication called pitavastatin can prevent cardiovascular disease in people with HIV.
David Heitz